J. Laird
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
- Peptidase Inhibition and Analysis
-
- Neuroendocrine Tumor Research Advances
Papers in
- Oncology 8
- Lung Cancer Research Studies 4
- PARP inhibition in cancer therapy 4
- Cancer Treatment and Pharmacology 2
- Neutropenia and Cancer Infections 2
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Benjamin H. Lok (8 shared papers)Charles M. Rudin (5 shared papers)John T. Poirier (5 shared papers)Joshua K. Sabari (1 shared paper)Jennifer Ma (5 shared papers)Elisa de Stanchina (4 shared papers)Andrew Bell (3 shared papers)John Zalcberg (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Journal of Clinical Oncology (2 papers)European Journal of Cancer (2 papers)Practical Radiation Oncology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
J. Laird
16 papers receiving 604 citations
Peers
Comparison fields: 5 of 59
- Oncology 387
- Epidemiology 130
- Gastroenterology 20
- Pulmonary and Respiratory Medicine 116
- Cancer Research 49
Countries citing papers authored by J. Laird
This map shows the geographic impact of J. Laird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Laird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Laird more than expected).
Fields of papers citing papers by J. Laird
This network shows the impact of papers produced by J. Laird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Laird. The network helps show where J. Laird may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Laird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 337 | |
| 2 | 1997 | 69 | |
| 3 | 2018 | 58 | |
| 4 | 2018 | 34 | |
| 5 | 1993 | 21 | |
| 6 | 1994 | 18 | |
| 7 | Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. | 1987 | 18 |
| 8 | 2019 | 16 | |
| 9 | 2017 | 13 | |
| 10 | 1995 | 10 | |
| 11 | 2017 | 7 | |
| 12 | 2023 | 6 | |
| 13 | 2021 | 3 | |
| 14 | 2009 | 2 | |
| 15 | 2018 | 2 | |
| 16 | 2017 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2024 | 0 |
About J. Laird
J. Laird is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Surgery and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 615 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), PARP inhibition in cancer therapy (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Cancer therapeutics and mechanisms (2 papers), Cancer Treatment and Pharmacology (2 papers), Gastroesophageal reflux and treatments (2 papers), Neutropenia and Cancer Infections (2 papers) and Histiocytic Disorders and Treatments (2 papers). The work is most often cited by research in Oncology (387 citations), Epidemiology (130 citations), Gastroenterology (20 citations), Pulmonary and Respiratory Medicine (116 citations) and Cancer Research (49 citations). J. Laird has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Benjamin H. Lok, Charles M. Rudin, John T. Poirier, Joshua K. Sabari, Jennifer Ma, Elisa de Stanchina, Andrew Bell, John Zalcberg, Karen Chau and Monica Chelius. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, European Journal of Cancer, Practical Radiation Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.